Sofosbuvir Recruiting Phase 4 Trials for Hepatitis C Viral Infection / End Stage Liver Diseases Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03208127DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant